Rani Therapeutics Holdings (RANI) EBT Margin (2020 - 2026)
Rani Therapeutics Holdings' (RANI) quarterly EBT Margin came in at 606.21% in Q1 2026, up 679961.0% year-on-year from N/an in Q1 2025, and down 2.66% quarter-over-quarter from 590.49% in Q4 2025.
Rani Therapeutics Holdings (RANI) EBT Margin (2020 - 2026) Analysis & Trends
Rani Therapeutics Holdings' EBT Margin history runs 5 years deep, the most recent figure standing at 606.21% for Q1 2026.
- On a quarterly basis, EBT Margin rose 679961.0% year-over-year to 606.21% in Q1 2026; TTM through Mar 2026 was 1332.79%, a 366455.0% increase from a year earlier, with the FY2025 full-year figure at 7136.56%, down 163228.0% from the prior year.
- EBT Margin eased to 606.21% in Q1 2026 per RANI's latest filing, from 590.49% in the prior quarter.
- Across five years, EBT Margin topped out at 590.49% in Q4 2025 and bottomed at 7405.81% in Q1 2025.
- The 3-year median for EBT Margin is 1067.79% (2024), against an average of 2532.97%.
- Across the five-year window, EBT Margin soared 93889 bps in 2025 and jumped 679961 bps in 2026, its largest moves.
- Year by year, EBT Margin stood at 1529.38% in 2024, then soared by 61 bps to 590.49% in 2025, then dropped by 3 bps to 606.21% in 2026.
- Per Business Quant, the three latest RANI EBT Margin figures stand at 606.21% (Q1 2026), 590.49% (Q4 2025), and 7405.81% (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Rani Therapeutics Holdings | 160.20 Mn | 167.33 Mn | - | -606.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -606.21% |
| Dec 31, 2025 | -590.49% |
| Mar 31, 2025 | -7,405.81% |
| Dec 31, 2024 | -1,529.38% |
| Jun 30, 2021 | -279.65% |
| Mar 31, 2021 | -734.79% |
| Dec 31, 2020 | -2,735.24% |
| Sep 30, 2020 | -2,664.81% |
| Jun 30, 2020 | -4,513.33% |